RB1 and cancer: First, although we experimentally validated our findings using PRCA cell lines and xenograft mouse models, other cancer types that also exhibit frequent RB1–NUDT15 codeletions (particularly small‐cell lung cancer) were not experimentally assessed, limiting the generalizability of our results across diverse tumor entities.